Bile Acids As Determinants of Postprandial Metabolism
PRIME
1 other identifier
interventional
150
1 country
1
Brief Summary
This study aims to understand how bile acids (BAs) appear in the bloodstream after eating and how this might affect inflammation and metabolism. To do this, we will measure changes in BA levels in 100 healthy women after they eat a high-fat and high-carbohydrate meal. Blood samples (a small amount of 500 µL) will be collected from a finger prick at 7 time points over 5 hours. In the second part of the study, 40 women will be invited back-20 with the highest and 20 with the lowest increases in BAs. These participants will eat the same test meal, and blood samples will be taken from a vein to study markers of health, metabolism, inflammation, and the gut microbiome. By exploring how BAs work in the body, this study hopes to find new ways to understand and prevent chronic diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 5, 2024
CompletedFirst Submitted
Initial submission to the registry
December 27, 2024
CompletedFirst Posted
Study publicly available on registry
January 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedMarch 12, 2025
December 1, 2024
1.2 years
December 27, 2024
March 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Plasma markers of intermediate metabolism and inflammation
Capillary blood samples (approximately 200 µL) were collected after a 12-hour fasting period and at different time points within a 5-hour interval after food intake to assess plasma metabolic and inflammatory markers, such as cytokines (IL-6 and TNF-α \[pg/mL\]), glucose levels \[mg/dL\], lipid profile parameters, including triglycerides, total cholesterol, and fractions \[mg/dL\], as well as bile acids \[µmol/L\]. These measurements aim to identify the physiological and metabolic responses to food intake.
1 day
Cytokines
IL-6 and TNF-α \[pg/mL\]
1 day
Glucose levels
glucose levels \[mg/dL\]
1 day
Lipid profile parameters
triglycerides, total cholesterol, and fractions \[mg/dL\].
1 day
Bile Acids
bile acids \[µmol/L\]
1 day
Secondary Outcomes (4)
Urine metabolome
1 day
24-hour dietary
1 day
Food Frequency Questionnaire (FFQ)
1 day
Visual Analog Score (VAS)
1 day
Study Arms (2)
General Population (First Phase)
EXPERIMENTAL150 healthy women will participate in the initial assessment of postprandial variability in bile acid (BA) levels after ingesting a test meal.
High Responders (Second Phase)
EXPERIMENTALA subgroup of 20 women with the highest postprandial increase in BA levels from the first phase will undergo further evaluation. A subgroup of 20 women with the lowest postprandial increase in BA levels from the first phase will undergo further evaluation.
Interventions
Ingestion of a high-fat, high-glucose meal to induce postprandial variations in bile acids and other metabolic markers.
Eligibility Criteria
You may qualify if:
- Women aged between 18 and 70 years
- Body mass index (BMI) between 18.5 and 34.9 kg/m²
You may not qualify if:
- Pregnant women
- History of bariatric surgery and/or intestinal resection
- Inflammatory bowel disease
- Celiac disease
- Liver disease
- Type 2 diabetes mellitus
- Casein allergy
- Alcohol consumption \>30 g/day
- Use of antimicrobial therapy within the past two months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Sao Paulolead
- Ministry of Education, Brazilcollaborator
- Fundação de Amparo à Pesquisa do Estado de São Paulocollaborator
Study Sites (1)
University of São Paulo
São Paulo, São Paulo, 05508+000, Brazil
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor PhD
Study Record Dates
First Submitted
December 27, 2024
First Posted
January 3, 2025
Study Start
March 5, 2024
Primary Completion
June 1, 2025
Study Completion
December 1, 2025
Last Updated
March 12, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share